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Abstract
Background: Mycobacterium tuberculosis (M. tuberculosis) modulates host immune response, mainly T cell responses
for its own survival leading to disease or latent infection. The molecules and mechanisms utilized to accomplish
immune subversion by M. tuberculosis are not fully understood. Understanding the molecular mechanism of T cell
response to M. tuberculosis is important for development of efficacious vaccine against TB.
Methods: Here, we investigated effect of M. tuberculosis antigens Ag85A and ESAT-6 on T cell signalling events in
CD3/CD28 induced Peripheral blood mononuclear cells (PBMCs) of PPD+ve healthy individuals and pulmonary TB
patients. We studied CD3 induced intracellular calcium mobilization in PBMCs of healthy individuals and TB patients
by spectrofluorimetry, CD3 and CD28 induced activation of mitogen activated protein kinases (MAPKs) in PBMCs of
healthy individuals and TB patients by western blotting and binding of transcription factors NFAT and NFκB by
Electrophorectic mobility shift assay (EMSA).
Results: We observed CD3 triggered modulations in free intracellular calcium concentrations in PPD+ve
healthy individuals and pulmonary TB patients after the treatment of M. tuberculosis antigens. As regards the
downstream signalling events, phosphorylation of MAPKs, Extracellular signal-regulated kinase 1 and 2 (ERK1/2)
and p38 was curtailed by M. tuberculosis antigens in TB patients whereas, in PPD+ve healthy individuals only
ERK1/2 phosphorylation was inhibited. Besides, the terminal signalling events like binding of transcription
factors NFAT and NFκB was also altered by M. tuberculosis antigens. Altogether, our results suggest that M.
tuberculosis antigens, specifically ESAT-6, interfere with TCR/CD28-induced upstream as well as downstream
signalling events which might be responsible for defective IL-2 production which further contributed in T-cell
unresponsiveness, implicated in the progression of disease.
Conclusion: To the best of our knowledge, this is the first study to investigate effect of Ag85A and ESAT-6
on TCR- and TCR/CD28- induced upstream and downstream signalling events of T-cell activation in TB patients. This
study showed the effect of secretory antigens of M. tuberculosis in the modulation of T cell signalling pathways. This
inflection is accomplished by altering the proximal and distal events of signalling cascade which could be involved in
T-cell dysfunctioning during the progression of the disease.
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Background
Tuberculosis (TB) is a major global health problem and
still remains one of the world’s deadliest communicable
diseases. In 2013, an estimated 9.0 million people devel-
oped TB and 1.5 million died from the disease, 360 000
of whom were HIV-positive [1]. The resurgence of TB
worldwide has intensified research efforts directed on
examining the host defence and pathogenic mechanisms
operative in Mycobacterium tuberculosis (M. tuberculosis)
infection. This is primarily because the organism lives
inside the cells and thus T cells, rather than antibodies are
required to eliminate bacteria [2, 3]. For proper T-cell ac-
tivation, T cell receptor (TCR) engagement with antigen
presenting cells (APCs) in presence of co-stimulation is
required and any variation in this, could lead to T-cell an-
ergy [4, 5]. The pathogenic mycobacteria resides inside
macrophage and involves in the inhibition of several host-
cell procedures, which allows its survival inside the host
cells. The host processes that are hampered by pathogenic
bacteria, the molecules and mechanisms utilized by patho-
genic mycobacteria to accomplish intracellular survival
are not fully understood. M. tuberculosis can modulate the
adaptive immune response using various mechanisms di-
rected on both the APCs and the T cells. M. tuberculosis
infected macrophages indirectly suppress T cell activation
by interfering with antigen processing and presentation.
Seitzer et al. showed decreased expression of CD3-ζ, a key
signalling domain of the TCR/CD3 complex in T cells
from human TB patients [6]. Wang et al. have shown that
the potent T cell antigen ESAT-6 can directly suppress
IFN-γ production in CD4+ T cells [7]. Directly inhibition
of polyclonal murine CD4+ T cell activation by M.
tuberculosis cell wall glycolipids by blocking ZAP-70
phosphorylation has been shown by Mahon et al. [8] and
later they extended their study by reporting ManLAM in-
duced inhibition of TCR signalling by interference with
ZAP-70, Lck and LAT phosphorylation in antigen-specific
murine CD4+ T cells and primary human T cells [9]. Re-
cently regulation of IFN-γ production by ERK and p38
MAPK signalling pathway and through SLAM costimula-
tion has been suggested in TB [10].
Secretory antigens of M. tuberculosis are immunodo-
minant and could have a role in the outcome of disease
by modulation of cell signalling pathways. Inhibition of
IFN-γ production through p38 MAPK pathway by
ESAT-6 has been reported in T cells from healthy indi-
viduals [11]. However, mechanisms of action of M.
tuberculosis antigens (specifically Ag85A and ESAT-6)
on TCR/CD28 mediated signalling in TB patients have
not been addressed till date hence needs to be investi-
gated. In the present study effect of Ag85A, ESAT-6
(secretory antigens), Purified protein derivative (PPD) (a
common antigen) and H37Rv (laboratory strain com-
monly used) was investigated on TCR/CD28-triggered
signalling which could be involved in T-cell dysfunction-
ing that leads to bacterial survival hence disease progres-
sion. Our objective was to study calcium mobilization,
activation of MAPKs and binding of NFAT and NFκB on
IL-2 promoter in peripheral blood mononuclear cells
(PBMCs) of pulmonary TB patients and healthy individ-
uals in presence or absence ofM. tuberculosis antigens.
Results
The concentration of antigens showing optimum prolif-
erative index in lymphocyte transformation test (LTT) in
PBMCs of pulmonary TB patients and PPD+ve healthy
individuals (data not shown) was considered as optimal
working concentration for further signalling experi-
ments. Standardized doses (5 μg/ml for Ag85A and
H37Rv and 10 μg/ml for ESAT-6) showed stimulation in-
dices (S.I.) more than two in PPD + ve healthy individ-
uals as well as in pulmonary TB patients. The levels of
S.I. with antigens (5 μg/ml for Ag85A and H37Rv and
10 μg/ml for ESAT-6) were significantly lower in TB
patients than PPD+ve healthy individuals and were also
significantly lower to the S.I. of PHA and PPD stimu-
lated cells (Additional file 1: Figure S1A-C). Serial con-
centrations of antigens (2.5 μg/ml, 5 μg/ml, 7.5 μg/ml,
10 μg/ml and 15 μg/ml) were used in LTT and optimal
dose of antigen found by LTT results was observed to
show the maximum effect.
M. tuberculosis antigens differentially curtail TCR
triggered intracellular calcium mobilization
To find out the effect of M. tuberculosis antigens on
intracellular calcium mobilization, we measured intracel-
lular calcium concentration by spectrofluorometer. We
assessed TCR-triggered calcium mobilization by adding
anti-CD3 antibody on cells pretreated with optimum
doses of M. tuberculosis antigens (Ag85A, ESAT-6, PPD
and H37Rv). We noticed that TCR triggered calcium
mobilization in PPD+ve healthy individuals was signifi-
cantly diminished by ESAT-6, but it was increased by
Ag85A, PPD and H37Rv though it was not statistically
significant. It showed that ESAT-6 inhibited the trans-
membrane calcium mobilization, while it was enhanced
by other antigens. TCR triggered transmembrane cal-
cium mobilization was significantly curtailed in pulmon-
ary TB patients, by Ag85A and ESAT-6. PPD and H37Rv
also inhibited the mobilization but it was not statistically
significant (Fig. 1).
M. tuberculosis antigens modulate TCR/CD28-induced
MAPK activation
To determine whether M. tuberculosis antigens modulate
TCR and TCR/CD28 induced MAPK activation, we mea-
sured phosphorylation of ERK ½ and p38 by Western blot.
Phosphorylation of MAPKs was studied in Ag85A, ESAT-
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6, PPD and H37Rv stimulated cells of PPD+ve healthy in-
dividuals and pulmonary TB patients. Although there was
notable individual variation, TCR/CD28 induced phos-
phorylation of ERK1/2 was observed to be significantly re-
duced by ESAT-6 in healthy individuals, while H37Rv
significantly increased phosphorylation of ERK ½. Ag85A
had no significant effect on activation of ERK ½, though
PPD increased phosphorylaion but not significantly. How-
ever, in pulmonary TB patients significant inhibition of
TCR/CD28 triggered ERK1/2 phosphorylation by Ag85A
and ESAT-6 was observed. PPD had no effect on phos-
phorylation of ERK ½ and H37Rv decreased but not sig-
nificantly (Fig. 2a and b). The phosphorylation of p38 in
TCR/CD28 induced cells was also analysed after stimula-
tion with M. tuberculosis antigens. No effect of Ag85A,
ESAT-6, PPD and H37Rv on p38 phosphorylation in PPD
+ve healthy individuals was noted. On the other hand
Ag85A and ESAT-6 significantly curtailed phosphoryl-
ation of p38 in pulmonary TB patients (Fig. 3a and b).
M. tuberculosis antigens differentially modulate TCR/
CD28-induced binding of NFκB and NFAT
DNA binding affinity of NFκB and NFAT on IL-2
promoter was also studied on TCR/CD28 activated
cells by Electrophoretic mobility shift assay (EMSA).
Ag85A, ESAT-6, PPD and H37Rv curtailed binding
affinity of NFκB in PPD+ve healthy individuals but
only ESAT-6 showed statistically significant reduction
in binding affinity. In pulmonary TB patients Ag85A
and ESAT-6 significantly curtailed the binding affinity
of NFκB (Fig. 4a and b). We also noted that Ag85A,
ESAT-6, PPD and H37Rv curtailed TCR/CD28 induced
binding activity of NFAT on IL-2 promoter in PPD+ve
healthy individuals and pulmonary TB patients both.
ESAT-6 was the only antigen that curtailed the binding
activity of NFAT significantly in healthy individuals and
patients both, but significant inhibition by PPD and
H37Rv was observed in patients only, though no sig-
nificant effect of Ag85A was noted in healthy and pa-
tients both (Fig. 5a and b).
Discussion
The outcome of TB mainly depends on T-cell re-
sponse, which is altered through multiple, but poorly
understood mechanisms. This study was designed to
investigate the impact of M. tuberculosis antigens on
T cell activation and their role in modulation of T-
cell physiology in disease, which still needs to be
defined. Here, we observed that patients with active pul-
monary TB have a significant diminished TCR triggered
intracellular calcium mobilization in response to secretory
M. tuberculosis antigens which is an important regulatory
signal-transduction stage of T cell activation. Further,
selective modulation in TCR/CD28-induced late signalling
events like MAPKs and binding of NFAT and NFκB which
is important in the activation of certain T cell genes for
cytokine production was also noted in presence of
M. tuberculosis antigens. The data suggests that these
alterations could explain the loss of a protective immune
response by reducing production of proinflammatory
Fig. 1 M. tuberculosis antigens alter free intracellular calcium concentration in PPD+ve healthy individuals and pulmonary TB patients. Peripheral
blood mononuclear cells (PBMCs) from 13 PPD+ve healthy donors and five pulmonary TB patients were stimulated with M. tuberculosis antigens
for 4 h. Fluorescence intensities were measured in ratio mode using Varian ECLIPSE spectrofluorometer as mentioned in material and methods.
Bar diagrams show changes in [Ca2+]i in anti CD3 and ionomycin treated cells of (a) PPD+ve healthy individuals (b) Pulmonary TB patients and
values in histogram are mean ± SEM. *, P < 0.05; **, P <0.005
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cytokines IL-2 against M. tuberculosis to some extent, and
it may also help us to figure out the mechanisms leading
to T cell dysfunction in TB.
Optimal T cell activation involves stimulation
through the TCR by MHC-peptide complex along
with additional signalling through co-stimulatory re-
ceptors. The TCR is a complex consisting intracellular
signal transducing domains, immunoreceptor tyrosine-
based activation motifs (ITAMs). Once phosphory-
lated, ITAMS become recruitment sites for ZAP-70, acti-
vated Zap-70 is then recruited to phosphorylate the
multiple transmembrane molecules. These signalling mol-
ecules activate multiple secondary signalling pathways in-
cluding Ca2+ signalling, Ras/MAP kinase, and protein
kinase C (PKC) pathways that ultimately activate several
transcription factors including NFAT, AP-1 and NF-κB
that are essential for full IL-2 gene expression and T cell
activation [12–14]. We observed that ESAT-6 curtailed
TCR triggered calcium mobilization in pulmonary TB pa-
tients and PPD+ve healthy individuals both but the inhib-
ition is more in patients as compared to healthy
individuals. On the other hand, Ag85A, PPD and H37Rv
diminished transmembrane calcium mobilization in pul-
monary TB patients but enhanced the transmembrane
calcium influx in PPD+ve healthy individuals. Present
study confirms that mycobaterial antigens: Ag85A, ESAT-
6, PPD and H37Rv, altered calcium signalling and conse-
quently might play a critical role in the pathogenesis of
Fig. 2 M. tuberculosis antigens modulate TCR- and TCR/CD28-induced phosphorylation of ERK1/2 in PPD+ve healthy individuals and pulmonary TB
patients. (a) Peripheral blood mononuclear cells (PBMCs) from six PPD+ve healthy donors and 12 pulmonary TB patients were stimulated with M.
tuberculosis antigens for 4 h. Cells were then activated with anti CD3 and anti CD28 antibodies (as mentioned in methodology). Phosphorylated ERK ½,
total ERK (p- ERK ½ and tERK, respectively) and β- Actin expression were determined by western blot. One representative blot of healthy individual and
TB patient is shown, where Lane 1- Control, Lane 2- anti CD3 stimulated, Lane 3- anti CD3 + anti CD28 stimulated, Lane 4- anti CD3 + anti CD28
stimulated in presence of Ag85A, Lane 5- anti CD3 + anti CD28 stimulated in presence of ESAT-6, Lane 6- anti CD3 + anti CD28 stimulated in presence
of PPD and Lane 7-anti CD3 + anti CD28 stimulated in presence of H37Rv. (b) Densitometry was performed, and the ratios of phosphorylated to total
protein expression were expressed as arbitrary units. *P < .05, ** P <0.005; *** P <0.005 by the Mann–Whitney U
Fig. 3 M. tuberculosis antigens modulate TCR- and TCR/CD28-induced p38 phosphorylation in PPD+ve healthy individuals and pulmonary TB patients.
(a) Peripheral blood mononuclear cells (PBMCs) from six PPD + ve healthy donors and 12 pulmonary TB patients were stimulated with M. tuberculosis
antigens for 4 h. Cells were then activated with anti CD3 and anti CD28 antibodies (as mentioned in methodology). Phosphorylated p38, total p-38
(p- p38 and tp38, respectively) and β- Actin expression were determined by western blot. One representative blot of each study case is shown where
Lane 1- Control, Lane 2- anti CD3 stimulated, Lane 3- anti CD3 + anti CD28 stimulated, Lane 4- anti CD3 + anti CD28 stimulated in presence of Ag85A,
Lane 5- anti CD3 + anti CD28 stimulated in presence of ESAT-6, Lane 6- anti CD3 + anti CD28 stimulated in presence of PPD and Lane 7-anti CD3 + anti
CD28 stimulated in presence of H37Rv. (b) Densitometry was performed, and the ratios of phosphorylated to total protein expression were expressed
as arbitrary units. *P < .05, ** P <0.005; *** P <0.005 by the Mann–Whitney U test
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the disease. Altered calcium signalling and other signalling
events has been noted in leprosy patients and T cell lines
and modulation by lipid and soluble fraction of M. leprae
lysates was shown which could play a major role in the
pathogenesis [15–19]. Our results are in close concord-
ance with other reports where PBMCs from patients with
leprosy have been reported to have reduced cytosolic
[Ca+2]i concentrations [16, 17]. In macrophages cur-
tailment of [Ca+2]i levels by M. tuberculosis has been
shown, which could be linked with reduced phagosome-
lysosome fusion, thus for increased survival of mycobac-
teria [20]. Only one report is available on intracellular
calcium modulation by H37Rv in newly diagnosed and
treated TB patients and PPD+ve and PPD-ve healthy
controls [21]. In addition, we used PPD and immuno-
dominant M. tuberculosis secretory antigens. On the
contrary, it has been previously reported that ESAT-6
did not affect phosphorylation of ZAP-70 and intra-
cellular calcium levels but ESAT-6 inhibits T cell
immune responses by affecting downstream signalling
molecules [7].
The importance of the MAPKs signal transduction
pathway in controlling many aspects of immune-
mediated inflammatory responses has made it a priority
for research, related to many human diseases. Therefore,
we further studied downstream signalling events such as
activation of MAPKs and nuclear translocation of tran-
scription factors NFκB and NFAT, important events for
both cytokine production and cell activation. Interest-
ingly, we observed that ESAT-6 significantly curtailed
TCR/CD28 induced phosphorylation of ERK1/2 in
healthy individuals and pulmonary TB patients both. We
did not observe any effect on p38 phosphorylation in
TCR/CD28 induced cells of healthy individual after
treatment with M. tuberculosis antigen whereas in pul-
monary TB patients Ag85A and ESAT-6 significantly
curtailed p38 phosphorylation. Palma-Nicholas [22] re-
ported down-modulation of MAPK–ERK1/2 pathway in
Fig. 4 M. tuberculosis antigens modulate TCR- and TCR/CD28-induced DNA binding affinity of NFκB to the promoter of IL-2 cytokine in PPD+ve
healthy individuals and pulmonary TB patients. (a) Peripheral blood mononuclear cells (PBMCs) from 11 PPD+ve healthy donors and 10 pulmon-
ary TB patients were stimulated with M. tuberculosis antigens for 4 h. Cells were then activated with anti CD3 and anti CD28 antibodies (as men-
tioned in methodology). Nuclear lysates were prepared and binding affinity of NFκB was determined by EMSA. One representative blot of each study
case is shown where Lane 1- Control, Lane 2- anti CD3 stimulated, Lane 3- anti CD3 + anti CD28 stimulated, Lane 4- anti CD3 + anti CD28 stimu-
lated in presence of Ag85A, Lane 5- anti CD3 + anti CD28 stimulated in presence of ESAT-6, Lane 6- anti CD3 + anti CD28 stimulated in
presence of PPD and Lane 7-anti CD3 + anti CD28 stimulated in presence of H37Rv. (b) Densitometry was performed, Histograms represent
mean band intensities. *P < .05, ** P <0.005; *** P <0.005 by the Mann–Whitney U test
Sharma et al. BMC Immunology  (2015) 16:67 Page 5 of 10
total spleen cells from naive BALB/c mice by the cell-
surface lipid di-O-acyl-trehalose (DAT), which further
leads to lowering of Th-1 type cytokine production. As
per our knowledge ours is the first study where differen-
tial modulation of TCR or TCR/CD28 induced down-
stream signalling events like MAPKs in the PBMCs of
pulmonary TB patients has been observed. The finding
suggests modulation of ERK1/2 and p38 both or majorly
p38 in T cells by M. tuberculosis that could lead to T cell
dysfunction or low Th1 cytokine production. Inhibition
of IFN-γ by ESAT-6 in human T cells through p38
MAPK has been reported earlier [11], however, our ob-
servation of inhibition of p38 by Ag85A in TB patients
is a novel information and confirms the role of p38 in
the T cell dysfunction. Similar to our findings differential
modulation of downstream signalling events like MAPKs
by M. leprae antigens stimulated T cells from leprosy
patients have been reported earlier [16, 17]. Further,
diminished and differential phosphorylation of MAPKs
by M. leprae antigens in T cell lines after stimulation
with anti CD3 or anti CD3+CD28 has also been
reported [18, 19]. Effect of secretory protein ESAT-6
of M. tuberculosis in the modulation of macrophage
signalling pathways particularly ERK1/2 MAPK pathway
has been shown in one study [23].
Further, binding affinity of NFκB and NFAT of antigen
treated cells in pulmonary TB patients and in PPD+ve
healthy individuals was also assessed by EMSA. We ob-
served that ESAT-6 significantly reduced the binding of
NFκB in healthy individuals and pulmonary TB patients.
We also noticed curtailment of binding activity of NFAT
in anti CD3+CD28 stimulated cells in pulmonary TB pa-
tients after treatment with ESAT-6, PPD and H37Rv.
ESAT-6 induced cells were showing significant inhibition
of NFAT binding in pulmonary TB patients and healthy
individuals both. Our findings of reduced NFAT binding
in ESAT-6 stimulated cells in healthy individuals and TB
patients could be correlated with the reduced Ca2+
Fig. 5 M. tuberculosis antigens modulate TCR- and TCR/CD28-induced DNA binding of NFAT to the promoter of IL-2 cytokine in PPD+ve healthy
individuals and pulmonary TB patients. (a) Peripheral blood mononuclear cells (PBMCs) from 11 PPD+ve healthy donors and 10 pulmonary TB
patients were stimulated with M. tuberculosis antigens for 4 h. Cells were then activated with anti CD3 and anti CD28 antibodies (as mentioned in
methodology). Nuclear lysates were prepared and binding affinity of NFAT was determined by EMSA. One representative example of each study case
is shown where Lane 1- Control, Lane 2- anti CD3 stimulated, Lane 3- anti CD3 + anti CD28 stimulated, Lane 4- anti CD3 + anti CD28 stimulated in
presence of Ag85A, Lane 5- anti CD3 + anti CD28 stimulated in presence of ESAT-6, Lane 6- anti CD3 + anti CD28 stimulated in presence of PPD and
Lane 7-anti CD3 + anti CD28 stimulated in presence of H37Rv. (b) Densitometry was performed, Histograms represent mean band intensities. *P < .05,
** P <0.005; *** P <0.005 by the Mann–Whitney U test
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mobilization of ESAT −6 stimulated cells in healthy and
patients both. Calcium is an essential element in many
T-cell responses, including a pathway that leads to the
movement of a major transcription factor, NFAT, from
the cytoplasm into the nucleus where NFAT supports
the transcription of genes required for the expression of
the T cell growth-promoting cytokines IL-2 [13]. No
study on the expression of NFkB and NFAT in activated
T cells in TB patients is available till date, however, Zea
et al. [24] have noticed reduced expression of p65 of
NFkB in T cells of pulmonary TB patients. Tchou- Wong
et al. [25] revealed specific binding of nuclear protein to
the NFkB site upon induction with M. tuberculosis in
human monocytic leukemic cell line THP-1. Impaired
nuclear translocation of NFκB and NFAT was also
noticed in leprosy patients [15–17].
While inhibition of T-cell activation is a novel obser-
vation for M. tuberculosis, it has been shown to occur
with other pathogens. These include bacteria, viruses,
and protozoan parasites. Bacterial toxins, including those
from Helicobacter pylori and Bacillus anthracis, can sup-
press TCR signalling by blocking calcium influx and
MAPKs, respectively [26–28]. Salmonella enterica may
also express a protein(s) that can down-modulate TCR
expression [29].
Our study indicates that M. tuberculosis has several
ways to destabilize the host’s T-cell response besides
what is already established. Although previous studies of
cell signalling pathways in TB have contributed upto
some extent to our knowledge of their role in host pro-
tective immune responses, a number of critical questions
are not well understood. Research into the development
of TB vaccines and immunodiagnostics has focused on
the proteins released by M. tuberculosis, because these
antigens are thought to induce protective cell mediated
immunity and immune responses of diagnostic value.
Ag85A and ESAT-6 are widely studied for their potential
to trigger effective host immune responses against TB,
but very little is known regarding their role in the T cells
signalling mechanisms underlying proinflammatory cyto-
kine secretion by T cells. Our data demonstrate that the
stimulation of human peripheral blood cells in vitro with
the Ag85A and ESAT-6 antigens of M. tuberculosis
markedly down modulated TCR activation by reducing
activation of T cells by affecting upstream as well as
downstream TCR signalling events. We suggest that
these mycobacterial antigens can affect activation of
intracellular T cell signalling pathways, such as calcium
mobilization, MAPKs that are required for production of
IL-2. Further work is required to delineate the molecular
mechanisms underlying these effects, to better under-
stand interactions between M. tuberculosis and human
immune system and to facilitate development of ESAT-6
and Ag85A-based vaccines.
Conclusion
This study has shown that a significant number of the
patients with pulmonary TB had alterations in the ex-
pression of several T cell signal-transduction proteins,
alterations that were similar to those reported earlier in
patients with leprosy. The similarity of T cell signal-
transduction alterations in diseases with different patho-
physiological characteristics suggests the possibility that
a common mechanism causes such changes. Follow-up
studies are needed to determine whether such alter-
ations revert after successful treatment and also whether
these can be modulated by immunotherapy. It would
also be of interest to know variations in different forms
of tuberculosis and determine relationship with activa-
tion of different cytokines. These observations of molecu-
lar and functional characteristics in TB may provide new
tools to analyse and monitor patients, to reveal how these
characteristics affect the development of immune dysfunc-
tion and to study new pathways to block suppressor
mechanisms. This endeavour will enhance our knowledge
of disease pathogenesis, contributing to a better under-
standing of the immune response to M. tuberculosis.
Methods
Study subjects
During the study period of two years 2008–2010, we re-
cruited 30 human immunodeficiency virus (HIV) - sero-
negative patients with TB diagnosed at State Tuberculosis
Demonstration Centre (STDC), Agra. The diagnosis of TB
was established based on clinical and radiological data to-
gether with the positive identification of acid-fast bacilli in
sputum. Fresh active pulmonary TB cases were included
in the study. Patients recruited before initiation of Anti
TB Treatment (ATT of 2 months intensive phase of
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol and
4 months continual phase of Isoniazid and Rifampicin)
and receiving ATT for less than a month were considered
as fresh case as per RNTCP guidelines (Revised National
Tuberculosis Control Program) [30]. We also included 27
healthy adults with no history of tuberculosis who were
working in the National JALMA Institute for leprosy and
other Mycobacterial Diseases, Agra. They showed absence
of any clinical disease and were positive for the purified
protein derivative (PPD). The study was carried after
taking the approval from Institutional human Ethics
Committee set up as per the guidelines of Indian
Council of Medical Research, New Delhi, India. Twenty
ml of blood sample was collected from all participants
after taking informed written consent.
Antigen
Lyophilized M. tuberculosis antigens (Ag85A, ESAT-6
and whole cell lysate of H37Rv), used in this study were
provided by J. Belisle (Colorado State University, Denver,
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CO, USA) through a TB Research Materials and Vaccine
Testing Contract (NIH Contract HHSN266200400091C/
ADB Contract NOI-AI-40091). PPD (RT-49) was pro-
cured from Statens Serum Institute, Copenhagen,
Denmark. PPD and whole cell lysate of H37Rv were used
as positive antigen control. PHA was procured from
(Sigma, St. Loius, MO, USA) and used as positive con-
trol only in LTT experiments. All antigens were dis-
solved in filtered Phosphate buffered saline (PBS) pH 7.4
to make 1 mg/ml concentration.
Cell preparation and reagents
Study was performed on peripheral blood mononuclear
cells (PBMCs) isolated from buffy coat obtained from
blood of pulmonary TB patients and PPD+ve healthy
individuals, by density gradient centrifugation over
Ficoll- HyPaque (Sigma, St. Loius, MO, USA). Cells were
maintained in RPMI-1640 medium supplemented with
5 % heat inactivated FBS (Hyclone, Utah, USA) with
2 mM L-glutamine and 1× antibiotic–antimycotic cocktail
(Sigma, St. Loius, MO, USA). Cultures were maintained
with 5 % CO2 at 37 °C in a humidified chamber. Experi-
ments were performed with cell viability >95 % as deter-
mined by Trypan blue exclusion test.
Mouse IgG anti-human pure CD3 (clone UCHT1), Iono-
mycin, goat anti-mouse-IgG (GAM), phenylmethylsulphonyl
fluoride (PMSF), sodium orthovanadate, anti-protease cock-
tail, Bradford reagent and Nuclear protein extraction kit
were purchased from Sigma, St. Louis, MO, USA. Fura-2/
AM was procured from Calbiochem, La Jolla, USA. Anti-
human CD3 (clone HIT3-α), anti-human CD28 (clone
CD28.2) were procured from BD Biosciences, CA, USA.
Phospho-ERK1/2 and phospho-p38MAPK antibodies
were procured from Cell Signalling Technology, MA,
USA. Anti-ERK −2, anti p38, β-actin and peroxidase-con-
jugated goat anti-mouse/goat anti-rabbit secondary
antibodies were purchased from Santacruz Technolo-
gies, CA, USA. ECL reagents were procured from
Millipore, MA, USA.
Quantification of transmembrane Ca2+ mobilisation
PBMCs (5 × 106/ml) from PPD+ve healthy individuals
(N = 13) and pulmonary TB patients (N = 5) were stimu-
lated with appropriate doses of M. tuberculosis antigens:
5 μg/ml Ag85A, 10 μg/ml of ESAT-6, 5 μg/ml PPD and
5 μg/ml of H37Rv, for 4 h in 37 °C CO2 incubator. After
incubation cells were washed with PBS, pH 7.4. Cells
were incubated with Fura-2/AM at 1 μM concentration
for 30 min at 37 °C in loading buffer [(in mM): NaCl,
110; KCl, 5.4;NaHCO3, 25; MgCl2, 0.8;KH2PO4, 0.4;
HEPES, 20;Na2HPO4, 0.33; CaCl2, 1.2. pH 7.4]. After
loading, cells were washed three times (500 × g for 5 min)
and remained suspended in the identical buffer. [Ca2+]i
was measured as reported elsewhere [31]. Fluorescence in-
tensities were measured in ratio mode using Varian
ECLIPSE spectrofluorometer equipped with Fast filter
accessory (Varian Incorporation, St. Helens, Australia) at
340 and 380 nm (excitation filters) and 510 nm (emission
filter). Cells were stirred continuously throughout the ex-
periment. For anti CD3 stimulated calcium studies: after
stabilization of basal levels of cytosolic calcium, 10 μg/ml
of pure Anti-CD3 (Clone UCHT1) was added to cuvette.
For measurement of Fmax, Ionomycin 5 μM was added to
cuvette and for F min MnCl2 2 mM was added.
The intracellular concentrations of free Ca2+ [Ca2+]i,
were calculated by using the following equation: [Ca2+]i =
Kd × (R − Rmin)/(Rmax − R) × (Sf2/Sb2). A value of
224nM for Kd was added into the calculations. Rmax and
Rmin values were obtained by addition of ionomycin
(5 μM) and MnCl2 (2 mM), respectively. All experiments
were performed at 37 °C.
Treatment and activation of cells
PBMCs (5 × 106/ml) were stimulated with appropriate
doses of M. tuberculosis antigens: 5 μg/ml Ag85A, 10 μg/
ml of ESAT-6, 5 μg/ml PPD and 5 μg/ml of H37Rv, for
four hours in 37 °C CO2 incubator, then stimulated with
or without anti-CD3 antibody (10 μg/ml) alone for 15 min
and then with anti-CD28 antibody (5 μg/ml) for 10 min at
4 °C. Further, cross linking was done using GAM-IgG
(5 μg/ml) for 15 min at 37 °C.
Western blot analysis of MAPKs activation
Antigen stimulated and anti CD3 and CD28 activated
cells from PPD+ve healthy individuals (N = 6) and pul-
monary TB patients (N = 12) were treated with chilled
PBS and then lysed with 50 μl of buffer (HEPES 20 mM,
pH 7.3; EDTA1mM; EGTA 1 mM; NaCl 0.15 mM; Tri-
ton X-100 1 %; glycerol 10 %; PMSF 1 mM; sodium
orthovanadate 2 mM; anti-protease cocktail). After cen-
trifugation (13,000 × g for 5 min), cell lysates were used
immediately or stored at −80 °C. The protein contents
were determined with Bradford reagent. Denatured pro-
teins (30 μg) were separated by SDS-PAGE (10 %) and
transferred to polyvinylidine difluoride (PVDF) mem-
branes. Immunodetection of phosphorylated forms of
ERK1/2 and p38MAPK was performed using 2 μg/ml of
phospho-specific antibodies in TBS with 2.5 % BSA with
overnight incubation at 4 °C. After washing with TBST
(TBS with 0.05 % Tween-20), PVDF membranes were
treated with peroxidase-conjugated goat anti-mouse/
anti-rabbit secondary antibodies and peroxidase activity
was detected with ECL reagents. Equal loading of the
proteins was confirmed after striping the blot and
reprobing for total forms of ERK-2/β-actin. Densitometric
analysis of bands was performed using Quantity OneTM
software (Bio-Rad, Hercules, USA).
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Purification of nuclear proteins for EMSA
Nuclear extracts were prepared as described in Cell Lytic
NuCLEAR Extraction kit. Briefly, antigens pre treated and
anti CD3 and anti CD3/CD28 activated cells from PPD
+ve healthy individuals (N = 11) and pulmonary TB pa-
tients (N = 10) were washed with ice-cold PBS and then
lysed by incubation in 100 μl of 1X lysis buffer (50 mM
Tris HCl, pH 7.5, with 10 mM MgCl2, 15 mM MgCl2,
15 mM CaCl2, and 1.5 M Sucrose, 1 μl of 0.1 M DTT and
1 μl of protease inhibitor cocktail on ice for 15 min.
Nuclei were pelleted by centrifugation at 10,000xg for 30 s
at 4 °C, the supernatant was saved as the cytoplasmic
extract, and the nuclear pellet was resuspended in
100 μl of extraction buffer (20 mM HEPES, pH 7.9,
with 1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM EDTA,
25 %(v/v) Glycerol, 1 μl of 0.1 M DTT and 1 μl of
protease inhibitor cocktail). The tubes were mounted
on a vortex mixture and agitated at medium to high
speed for 15–30 min. Tubes were then centrifuged at
20,000 x g for 5 min, and the supernatant was nuclear
extract which is then transferred in a fresh chilled tube
and were stored at −80 °C.
Labelling of probes for EMSA
Synthetic complementary oligonucleotides were 3′- bio-
tinylated using the biotin 3′-end DNA labeling kit
(Pierce- Endogen, Illinois, USA) according to the manu-
facturer’s instructions and annealed for two hours at
room temperature. The sequence of the oligonucleotide
used for NFAT was 5′-GATCTTTACATTGGAAAA
TTTTAT- 3′ [32] and for NF-κB, 5′-AGCTTAGAGGG
GACTTTCCGAGAGGA-3′ [33].
Analysis of EMSA
Binding reactions were carried out for 20 min at
room temperature in the presence of 50 ng/ml
polyI:C, 0.05 % NP-40, 5 mM MgCl2, 10 mM EDTA,
and 2.5 % glycerol in 1× binding buffer (LightShiftTM
chemiluminescent EMSA kit, Pierce-Endogen, Illinois,
USA) using 20 fmol of biotin-end-labeled target DNA
with 4 μg of nuclear extract. Assays were loaded onto
native 4 % polyacrylamide gels pre-electrophoresed for
60 min in 0.5× Tris-borate/EDTA and then gels were elec-
trophoresed at 100 V before transferring to positively
charged nylon membrane (Immobilion-NY, Millipore,
MA, USA) in 0.5× Tris-borate/EDTA at 100 V for 30 min.
Transferred DNA was UV cross-linked to the membrane
at 120 mJ/cm2 and detected using horseradish peroxidase-
conjugated streptavidin as per manufacturer’s instructions.
Peroxidase activity was detected with Enhanced chemilu-
miniscence (ECL) reagents. Densitometric analysis of
bands was performed using Quantity OneTM software
(Bio-Rad, Hercules, USA).
Statistical analysis
We used GraphPad Prism v5.0 (La Jolla, USA) for statis-
tical analysis. The Mann–Whitney U test was used to
analyze differences between unpaired samples. P values
of <0.05 were considered statistically significant.
Additional file
Additional file 1: Figure S1. (A-C) Lymphocyte transformation test
for dose optimisation of Ag85A, ESAT-6 and H37Rv by using PBMCs
of healthy individuals (N = 10) and pulmonary TB (N = 10) patients
using H3-thymidine uptake assay. PHA and PPD were used as positive
control and wells with unstimulated cells were taken as control.
Lymphoproliferative responses of healthy individuals and pulmaonary
TB patients were calculated using different concentration (2.5, 5, 7.5,
10, 15, μg/ml) of antigens. Bar diagram showing mean ± SEM of
stimulation indices (S.I) of stimulated PBMC’s with different doses of
PHA, PPD, A85A, ESAT-6 and H37Rv. S.I was calculated according to
the formula: SI ¼ Mean counts per minute of experimental wellsMean counts per minute of control wells (ZIP 160 kb)
Abbreviations
IFN-γ: Interferon gamma; IL-2: Interleukin 2; ESAT-6: Early secretory antigenic
target −6; PPD: Purified protein derivative; [Ca+2]i: Free intracellular calcium
concentrations.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BS performed all the experiments. RU and BD helped in experimentation.
NAK and VMK helped in concept and writing of the manuscript. BB helped
in recruitment of pulmonary TB patients. BJ* conceived and executed the
study. All authors read and approved the final manuscript.
Acknowledgments
Authors are thankful to ICMR for providing support for selective reagents. BS
and RU are supported by fellowship from ICMR. Authors are also thankful to
all study participants. Authors duly acknowledge support of Dr. K. N. Balaji in
manuscript preparation and Mr. M. Alam for sample collection. The support
provided by staff of Department of Molecular Biology and Microbiology and
Department of Biochemistry, NJIL & OMD, Agra is highly acknowledged.
Author details
1Department of Immunology, National JALMA Institute for Leprosy and
Other Mycobacterial Diseases (ICMR), Dr.M.Miyazaki Marg, Tajganj, Agra
282001, India. 2UPRES EA 4183 Lipides & Signalisation Cellulaire, Faculté des
Sciences de la vie, Université de Bourgogne, 6, Boulevard Gabriel, Dijon
21000, France. 3Formerly in Department of Health Research and ICMR, Ansari
Nagar, New Delhi-29, India. 4State TB Training & Demonstration Centre, S.N.
Medical College Campus, Agra 282 002, India.
Received: 19 May 2015 Accepted: 20 October 2015
References
1. World Health Organization. Global tuberculosis report. Geneva: WHO/HTM/
TB; 2014.
2. Flynn JL. Immunology of tuberculosis and implications in vaccine
development. Tuberculosis. 2004;84:93–101.
3. Ferraz JC, Melo FB, Albuquerque MF, Montenegro SM, Abath FG. Immune
factors and immunoregulation in tuberculosis. Braz J Med Biol Res.
2006;11:1387–97.
4. Schwartz RH. Cell culture model for T lymphocyte clonal anergy. Science.
1990;248:1349–56.
5. Zheng Y, Zha Y, Gajewski TF. Molecular regulation of T cell anergy. EMBO
Rep. 2008;9:50–5.
Sharma et al. BMC Immunology  (2015) 16:67 Page 9 of 10
6. Seitzer U, Kayser K, Hohn H, Entzian P, Wacker HH, Ploetz S, et al. Reduced
T-cell receptor CD3ξ-chain protein and sustained CD3ε expression at the
site of mycobacterial infections. Immunology. 2001;104:269–77.
7. Wang XP, Barnes F, Dobos-Elder KM, Townsend JC, Chung Y, Shams H, et al.
ESAT-6 inhibits production of IFN-γ by Mycobacterium tuberculosis-
responsive human T cells. J Immunol. 2009;182:3668–77.
8. Mahon RN, Rojas RE, Fulton SA, Franko JL, Harding CV, Boom WH.
Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T cell
activation by interfering with proximal T-cell receptor signalling. Infect
Immun. 2009;10:4574–83.
9. Mahon RN, Sande OJ, Rojas RE, Levine AD, Harding CV, Boom WH.
Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signalling by
interference with ZAP-70, Lck and LAT phosphorylation. Cell Immunol.
2012;275:98–105.
10. Pasquinelli V, Rovetta AI, Alvarez IB, Jurado JO, Musella RM, Palmero DJ, et
al. Phosphorylation of mitogen-activated protein kinases contributes to
interferon γ production in response to mycobacterium tuberculosis. J Infect
Dis. 2013;207:340–50.
11. Peng H, Wang X, Barnes PF, Tang H, Townsend JC, Samten B. The
Mycobacterium tuberculosis Early Secreted Antigenic Target of 6 kDa Inhibits
T Cell Interferon-γ production through the p38 Mitogen-activated Protein
Kinase Pathway. J Bio Chem. 2011;27:24508–18.
12. Iwashima M. Kinetic perspectives of T cell antigen receptor signalling:
A two-tier model for T cell activation. Immunol Rev. 2003;191:196–210.
13. Huse M. The T-cell-receptor signalling network. J Cell Sci. 2009;122:
1269–273.
14. van Leeuwen JEM, Samelson LE. T cell antigen-receptor signal transduction.
Curr Opin Immunol. 1999;11:242–8.
15. Zea AH, Ochoa MT, Ghosh P, Longo DL, Moreno LH, Ochoa AC. Changes in
expression of signal transduction proteins in T-lymphocytes of patients with
leprosy. Infect Immun. 1998;66:499–504.
16. Chattree V, Khanna N, Rao DN. Alterations in T cell signal transduction by M.
leprae antigens is associated with downregulation of second messengers
PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy
patients. Mol Immunol. 2007;44:2066–77.
17. Sharma N, Sharma VK, Gupta A, Kaur I, Kaur S, Ganguly NK. Alterations in
early biochemical events following T-cell activation in leprosy patients. Clin
Immunol Immunopathol. 1998;88:142–9.
18. Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, et al.
Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/
CD28-induced signalling events: Insights into T-cell unresponsiveness in
leprosy. Mol Immunol. 2010;47:943–52.
19. Dagur PK, Sharma B, Upadhyay R, Dua B, Rizvi A, Khan NA, et al.
Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate
TCR- and CD28-triggered proximal biochemical events, leading to T-cell
unresponsiveness in mycobacterial diseases. Lipid Healt Dis.
2012;11:119–28.
20. Malik ZA, Denning GM, Klusner DJ. Inhibition of Ca2+ signalling by
Mycobacterium tuberculosis is associated with reduced phagosomelysosome
fusion and increased survival within human macrophages. J Exp Med.
2000;191:287–302.
21. Talreja J, Bhatnagar A, Jindal SK, Ganguly NK. Influence of Mycobacterium
tuberculosis on differential activation of helper T-cells. Clin Exp Immuno.
2003;131:292–8.
22. Palma-Nicolás JP, Hernández-Pando R, Segura E, Ibarra-Sánchez MJ,
Estrada-García I, Zentella-Dehesa A, et al. Mycobacterial di-O-acyl
trehalose inhibits Th-1cytokine gene expression in murine cells by
down-modulation of MAPK signalling. Immunobiology. 2010;215:143–52.
23. Ganguly N, Giang PH, Basu SK, Mir FA, Siddiqui I, Sharma P. Mycobaterium
tuberculosis 6-kDa Early Secreted Antigenic Target (ESAT-6) protein
downregulates Lipopolysaccharide induced c-myc expression by
modulating the Extracellular Signal Regulated Kinases ½. BMC Immunol.
2007;8:24–35.
24. Zea AH, Cullota KS, Ali J, Mason C, Park HJ, Zabaleta J, et al. Decreased
expression of CD3z and nuclear transcription factor kB in patiens with
tubercolsis: potential mechanisms and reversibility with treatment. J Infect
Dis. 2006;194:1385–93.
25. Tchou-Wong KM, Tanabe O, Chi C, Yie TA, Rom WN. Activation of NFκB in
Mycobacterium tuberculosis– induced Interleukin-2 receptor expression in
mononuclear phagocytes. Am J Respir Crit Care Med. 1999;159:1323–9.
26. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, et al. The
Helicobacter pylori vacuolating toxin inhibits T cell activation by two
independent mechanisms. J Exp Med. 2003;198:1887–97.
27. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori
vacuolating cytotoxin inhibits T lymphocyte activation. Science.
2003;301:1099–100.
28. Comer JE, Chopra AK, Peterson JW, Konig R. Direct inhibition of T- lymphocyte
activation by anthrax toxins in vivo. Infect Immun. 2005;73:8275–81.
29. Van der Velden AW, Dougherty JT, Starnbach MN. Down-modulation of TCR
expression by Salmonella enterica serovar Typhimurium. J Immunol.
2008;180:5569–74.
30. Central TB Division. TB India 2014: RNTCP Annual Status Report. New Delhi:
Ministry of Health and Family Welfare; 2014: http://tbcindia.nic.in.
31. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with
greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–50.
32. Rooney JW, Hodge MR, McCaffrey PC, Rao A, Glimcher LH. A common
factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO
J. 1999;13:625–33.
33. Cordle SR, Donald R, Read MA, Hawiger J. Lipopolysaccharide induces
phosphorylation of MAD3 and activation of c-Rel and related NF-kB proteins
in human monocytic THP-1 cells. J Biol Chem. 1993;268:11803–10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sharma et al. BMC Immunology  (2015) 16:67 Page 10 of 10
